GlaxoSmithKline Consumer Healthcare Pakistan Limited reported earnings results for the year ended December 31, 2017. For the year, the company reported sales of PKR 8,298,142,000 compared to PKR 5,375,804,000 a year ago. Operating profit was PKR 1,178,972,000 compared to PKR 857,618,000 a year ago. Profit before tax was PKR 1,170,838,000 compared to PKR 856,063,000 a year ago. Total profit after tax was PKR 706,815,000 or PKR 7.39 per share compared to PKR 545,465,000 or PKR 7.60 per share a year ago.